Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians.
- DOI
- 10.3390/diagnostics16121854
- Published
- 2026 Jun 15
- Container
- Diagnostics (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics16121854,
title = {Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians.},
author = {Wilson MP and Shaheen AA and Leung V and Tang A and Costa AF and Hurrell C and Low G},
year = {2026},
journal = {Diagnostics (Basel, Switzerland)},
doi = {10.3390/diagnostics16121854},
url = {https://doi.org/10.3390/diagnostics16121854}
}RIS
TY - JOUR TI - Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians. AU - Wilson MP AU - Shaheen AA AU - Leung V AU - Tang A AU - Costa AF AU - Hurrell C AU - Low G PY - 2026 JO - Diagnostics (Basel, Switzerland) DO - 10.3390/diagnostics16121854 UR - https://doi.org/10.3390/diagnostics16121854 ER -
APA
MP, W., AA, S., V, L., A, T., AF, C., C, H., & G, L. (2026). Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16121854
Source records
- pubmed · retrieved 2026-09-26T03:42:49.207Z